Semaglutide Reconstitution Calculator

FDA Approved

Calculate precise U-100 syringe units, concentration (mg/mL), and doses per vial for Semaglutide research.

Clinical Precision Tool

Semaglutide Dosage Calculator

U-100 Calibrated
Calculated Syringe Draw
16.7Units
➜ 0.167 mL volume
0 Units100 Units Max
Concentration
1.50 mg/mL
Tick Marks
16.7 ticks
OE
Written by OnePeptideShip Editorial Team
Reviewed by Dr. Aris Thorne, MD, Board Certified Endocrinology Advisor
Updated September 2026

Clinical Pharmacology & Mechanism of Action

Semaglutide is a revolutionary, long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. Structurally, it is heavily modified from native human GLP-1 (which degrades in the body in a matter of minutes).

To extend its half-life, researchers engineered Semaglutide with an 8-carbon fatty diacid chain attached to a lysine residue. This modification allows the peptide to bind strongly to serum albumin in the bloodstream, shielding it from rapid enzymatic degradation by DPP-4 (dipeptidyl peptidase-4).

Semaglutide exerts its primary effects by mimicking the incretin hormone GLP-1. It binds to and activates the GLP-1 receptor, which has profound metabolic downstream effects:

  • Appetite Suppression: It crosses the blood-brain barrier and stimulates neurons in the hypothalamus that regulate satiety, severely reducing hunger signals .
  • Gastric Emptying: It significantly slows the rate at which the stomach empties into the duodenum, leading to prolonged feelings of fullness.
  • Insulin Secretion: It enhances glucose-dependent insulin secretion from pancreatic beta cells while suppressing inappropriate glucagon secretion.

Pharmacokinetics & Half-Life

Because of the albumin-binding fatty acid chain, Semaglutide boasts an exceptionally long pharmacokinetic profile compared to first-generation GLP-1s like Exenatide or Liraglutide.

  • Half-life: Approximately 7 days (165 hours).
  • Steady State: Due to the 7-day half-life, it takes roughly 4 to 5 weeks of consistent weekly dosing for the drug to reach a steady-state plasma concentration in the bloodstream. This is a critical factor for titration; researchers must not escalate doses too quickly, as the drug is still accumulating in the system from previous weeks.

Standard Research Dosing Protocols (Titration)

Clinical trials for Semaglutide rely on a strict "titration schedule" to mitigate severe gastrointestinal side effects (nausea, vomiting, diarrhea). The body requires time to build a tolerance to delayed gastric emptying.

The standard research protocol involves escalating the dose every 4 weeks:

  1. Weeks 1 - 4 (Initiation): 0.25mg once weekly.
  2. Weeks 5 - 8: 0.5mg once weekly.
  3. Weeks 9 - 12: 1.0mg once weekly.
  4. Weeks 13 - 16: 1.7mg once weekly.
  5. Weeks 17+ (Maintenance): 2.4mg once weekly.

Note: Many researchers find extreme success at lower doses (0.5mg or 1.0mg) and choose to remain at those doses indefinitely without escalating to the 2.4mg maximum.

Reconstitution Math & Syringe Guide

Calculating Semaglutide can be challenging because vials often come in non-standard sizes (e.g., 3mg, 4mg, or 5mg) while doses are very small initially (0.25mg).

Step-by-Step Reconstitution (3mg Vial)

  1. Swab the rubber stoppers of your 3mg Semaglutide vial and your Bacteriostatic Water.
  2. Using a sterile mixing syringe, draw exactly 2mL of Bacteriostatic Water.
  3. Inject the water into the 3mg Semaglutide vial, aiming at the glass wall to prevent shearing the peptide puck.
  4. Swirl gently until the liquid is entirely clear.

The Math for an Initiation Dose (0.25mg):

  • 3mg total in the vial.
  • You added 2mL of water.
  • Therefore, the concentration is 1.5mg per 1mL.
  • You need a 0.25mg dose. Divide the dose by the concentration: 0.25 ÷ 1.5 = 0.167mL.
  • 0.167mL = 16.7 units on a U-100 syringe.

For a 5mg vial mixed with 2mL of water, the concentration is 2.5mg/mL. A 0.25mg dose would require exactly 0.1mL, which is 10 units.

Common Mistakes & Troubleshooting

  • Rushing the Titration: The most common and dangerous mistake is skipping the 0.25mg starting dose. Because it takes 4-5 weeks for the peptide to reach steady-state accumulation, increasing the dose at week 2 or 3 often results in severe, debilitating nausea and vomiting.
  • Injecting Cold Peptide: Injecting Semaglutide immediately after taking it out of the refrigerator can cause a stinging sensation (Post-Injection Pain or PIP). Let the syringe sit at room temperature for 10-15 minutes before injecting.
  • Sulphur Burps: A common side effect of delayed gastric emptying is the fermentation of food in the stomach, leading to foul-smelling burps. This is mitigated by eating smaller meals and avoiding highly processed, fatty, or sugary foods during research.

Medical & Research Disclaimer

The information provided on this page, including all calculations, is for educational and laboratory research purposes only. It does not constitute medical advice. Peptides mentioned here are not approved for human consumption outside of FDA-approved clinical trials unless specified otherwise. Always consult a licensed healthcare provider before undertaking any new therapy.

Frequently Asked Questions

The standard initiation dose is 0.25mg once weekly for the first 4 weeks. This dose is sub-therapeutic for weight loss but is critical for allowing GI tolerance (your stomach to adapt to slowed gastric emptying). After 4 weeks, it escalates to 0.5mg, then 1.0mg, 1.7mg, and finally 2.4mg at 4-week intervals.

It depends on your vial size and water volume. Using a 3mg vial with 2mL of water (1.5mg/mL): 0.25mg = 16.7 units. Using a 5mg vial with 2mL of water (2.5mg/mL): 0.25mg = 10 units. Always use the calculator above for your specific configuration to avoid calculation errors.

Nausea is the most common side effect and is directly caused by Semaglutide slowing your gastric emptying. Food sits in the stomach longer, which triggers nausea receptors. This is why titration is mandatory - your body needs weeks to adapt. To minimize nausea: eat smaller meals, avoid fatty or processed foods, stay hydrated, and inject right before bed so you sleep through the worst of it.

Yes. The escalation schedule exists to reach maximum efficacy for a broad study population. If a subject is experiencing satisfactory weight loss and manageable side effects at 0.5mg or 1.0mg, there is no biological requirement to escalate further. Many clinical researchers maintain subjects at lower doses indefinitely.

Sulphur burps (or "egg burps") are a notorious side effect caused by delayed gastric emptying. Food stays in the stomach too long and begins fermenting, producing hydrogen sulfide gas. They are prevented by: eating smaller meals, cutting out processed high-fat and high-sugar foods, spacing meals 4-5 hours apart, and staying fully hydrated.

Semaglutide itself does not burn anything - it simply suppresses appetite, putting you in a caloric deficit. In any significant caloric deficit, the body catabolizes both fat and muscle tissue for energy. To preserve muscle mass during Semaglutide research, high daily protein intake (1.2-1.6g per kg of body weight) and regular resistance training are practically mandatory.

Reconstituted with Bacteriostatic Water and stored refrigerated at 2-8°C, Semaglutide remains stable and potent for approximately 28 days. Never freeze reconstituted Semaglutide. Lyophilized (dry) vials can be stored in the freezer for 1-2 years.

Related Research Calculators